Literature DB >> 2797459

Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis.

M Tsujihata1, T Yoshimura, A Satoh, I Kinoshita, H Matsuo, M Mori, S Nagataki.   

Abstract

We detected deposits of IgG, C3, and C9 (immune complexes) at the limb muscle motor end-plates (biceps brachii muscle) in 16 of 19 patients who exhibited only ocular signs and symptoms of myasthenia gravis that were improved by intravenous injections of edrophonium chloride. Circulating anti-acetylcholine receptor (anti-AChR) antibodies were negative in 6 of the 16 patients, but the motor end-plate fine structure in the postsynaptic regions was abnormal in all 16. Single-fiber EMG revealed no abnormalities in 8 of 13 patients studied. Our results indicate that the detection of immune complexes at the limb muscle end-plate provides a highly sensitive and confirmative method for diagnosing patients with minimal or atypical myasthenia gravis who have no detectable anti-AChR antibodies in their serum.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2797459     DOI: 10.1212/wnl.39.10.1359

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  Complement activation promotes muscle inflammation during modified muscle use.

Authors:  J Frenette; B Cai; J G Tidball
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

2.  Topographical relationships of intramuscular nerves and vessels of the motor endplates in the thigh and gluteal regions of human fetuses: an immunohistochemical study.

Authors:  Hyung Suk Jang; Kwang Ho Cho; Gen Murakami; Baik Hwan Cho
Journal:  Surg Radiol Anat       Date:  2015-12-20       Impact factor: 1.246

3.  C5a is not involved in experimental autoimmune myasthenia gravis pathogenesis.

Authors:  Huibin Qi; Erdem Tüzün; Windy Allman; Shamsher S Saini; Zurina R Penabad; Silvia Pierangeli; Premkumar Christadoss
Journal:  J Neuroimmunol       Date:  2008-05-01       Impact factor: 3.478

4.  Receptor clustering and pathogenic complement activation in myasthenia gravis depend on synergy between antibodies with multiple subunit specificities.

Authors:  Natalie Rose; Sebastian Holdermann; Nicholas S R Sanderson; Tobias Derfuss; Ilaria Callegari; Hyein Kim; Isabelle Fruh; Ludwig Kappos; Jens Kuhle; Matthias Müller
Journal:  Acta Neuropathol       Date:  2022-09-08       Impact factor: 15.887

5.  Complement deposition at the neuromuscular junction in seronegative myasthenia gravis.

Authors:  Werner Stenzel; Andreas Meisel; Sarah Hoffmann; Lutz Harms; Markus Schuelke; Jens-Carsten Rückert; Hans-Hilmar Goebel
Journal:  Acta Neuropathol       Date:  2020-03-10       Impact factor: 17.088

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.